Upfront Surgery May Be Avoidable in Very High-Risk NMIBC Responsive to BCG

Within 5 years, 22% of patients with very high-risk NMIBC treated with adequate BCG had disease progression Select patients with very high-risk nonmuscle-invasive bladder cancer (NMIBC) who respond to bacillus Calmette-Guerin (BCG) might avoid surgery.

Related Keywords

Madrid ,Spain ,Universitario Ram ,Daniel Subiela ,European Association Of Urology ,European Association ,Hospital Universitario Ram ,Universidad De Alcala ,European Urology ,